Norges Bank’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-270,770
| Closed | -$869K | – | 1888 |
|
|
2023
Q4 | $869K | Sell |
270,770
-379,302
| -58% | -$1.22M | ﹤0.01% | 1874 |
|
|
2023
Q3 | $2.06M | Sell |
650,072
-119,048
| -15% | -$377K | ﹤0.01% | 1824 |
|
|
2023
Q2 | $3.82M | Hold |
769,120
| – | – | ﹤0.01% | 1780 |
|
|
2023
Q1 | $3.8M | Sell |
769,120
-114,827
| -13% | -$567K | ﹤0.01% | 1827 |
|
|
2022
Q4 | $5.56M | Sell |
883,947
-39,062
| -4% | -$246K | ﹤0.01% | 1751 |
|
|
2022
Q3 | $9.97M | Hold |
923,009
| – | – | ﹤0.01% | 1543 |
|
|
2022
Q2 | $10.5M | Sell |
923,009
-1,150,508
| -55% | -$13.1M | ﹤0.01% | 1540 |
|
|
2022
Q1 | $18.9M | Buy |
2,073,517
+444,100
| +27% | +$4.05M | ﹤0.01% | 1425 |
|
|
2021
Q4 | $24.3M | Buy |
1,629,417
+453,421
| +39% | +$6.77M | 0.01% | 1368 |
|
|
2021
Q3 | $30.2M | Sell |
1,175,996
-394,633
| -25% | -$10.1M | 0.01% | 1214 |
|
|
2021
Q2 | $41M | Buy |
1,570,629
+610,458
| +64% | +$15.9M | 0.01% | 1088 |
|
|
2021
Q1 | $33.9M | Sell |
960,171
-176,037
| -15% | -$6.21M | 0.01% | 1204 |
|
|
2020
Q4 | $28.7M | Sell |
1,136,208
-94,884
| -8% | -$2.39M | 0.01% | 1348 |
|
|
2020
Q3 | $46.4M | Sell |
1,231,092
-170,939
| -12% | -$6.45M | 0.01% | 877 |
|
|
2020
Q2 | $60M | Buy |
1,402,031
+357,198
| +34% | +$15.3M | 0.02% | 725 |
|
|
2020
Q1 | $20.3M | Sell |
1,044,833
-19,747
| -2% | -$384K | 0.01% | 1231 |
|
|
2019
Q4 | $27.7M | Buy |
1,064,580
+48,117
| +5% | +$1.25M | 0.01% | 1329 |
|
|
2019
Q3 | $27.7M | Buy |
1,016,463
+275,623
| +37% | +$7.51M | 0.01% | 1265 |
|
|
2019
Q2 | $19.9M | Buy |
740,840
+340,840
| +85% | +$9.15M | 0.01% | 1508 |
|
|
2019
Q1 | $11.6M | Hold |
400,000
| – | – | ﹤0.01% | 1754 |
|
|
2018
Q4 | $10.8M | Buy |
+400,000
| New | +$10.8M | ﹤0.01% | 1712 |
|